aTYR PHARMA INC
aTYR PHARMA INC (ATYR) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 24 transactions totaling $1.3M, demonstrating a bullish sentiment with $1.2M in net insider flow. The most recent transaction on Feb 4, 2026 involved a sale of 1,118 shares valued at $1.1K.
ATYR Insider Activity Summary
Who Is Buying ATYR Stock?
No significant insider buying has been recorded for ATYR in the recent period.
Who Is Selling ATYR Stock?
No significant insider selling has been recorded for ATYR in the recent period.
Is aTYR PHARMA INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ATYR is bullish with an Insider Alignment Score of 95/100 and a net flow of $1.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ATYR Frequently Asked Questions
Understanding ATYR Insider Activity
Insider trading at aTYR PHARMA INC (ATYR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading ATYR stock, having executed 24 transactions in the past 90 days. The most active insider is Paul Schimmel (Executive), who has made 5 transactions totaling $1.1M.
Related Tools
Track aTYR PHARMA INC Insider Activity
Get notified when executives and directors at ATYR file new Form 4 transactions